Preprint · CC-BY
via OpenAlex
Implantation of bone marrow‐derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon
Ebughe Godwin, N. J. Young, Jayesh Dudhia, I. C. BEAMISH, R. K. W. SMITH
Equine Veterinary Journal · 2011 · ▲ 409 citations
Abstract
REASONS FOR PERFORMING STUDY: Mesenchymal stem (progenitor; stromal) cell (MSC) therapy has gained popularity for the treatment of equine tendon injuries but without reports of long-term follow-up. OBJECTIVES: To evaluate the safety and reinjury rate of racehorses after intralesional MSC injection in a large study of naturally occurring superficial digital flexor tendinopathy and to compare these data with those published for other treatments. METHODS: Safety was assessed clinically, ultrasonographically, scintigraphically and histologically in a cohort of treated cases: 141 client-owned treated racehorses followed-up for a minimum of 2 years after return to full work. Reinjury percentages were compared to 2 published studies of other treatments with similar selection criteria and follow-up. The number of race starts, discipline, age, number of MSCs injected and interval between injury and treatment were analysed. RESULTS: There were no adverse effects of the treatment with no aberrant tissue on histological examination. The reinjury percentage of all racehorses with follow-up (n = 113) undergoing MSC treatment was 27.4%, with the rate for flat (n = 8) and National Hunt (n = 105) racehorses being 50 and 25.7%, respectively. This was significantly less than published for National Hunt racehorses treated in other ways. No relationship between outcome and age, discipline, number of MSCs injected or injury to implantation interval was found. CONCLUSIONS: Whilst recognising the limitations of historical controls, this study has shown that MPC implantation is safe and appears to reduce the reinjury rate after superficial digital flexor tendinopathy, especially in National Hunt racehorses. POTENTIAL RELEVANCE: This study has provided evidence for the long-term efficacy of MSC treatment for tendinopathy in racehorses and provides support for translation to human tendon injuries.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/j.2042-3306.2011.00363.x
- Canonical
- link ↗
- Fetched
- 2026-06-21 MST
Cite this
APA
Godwin, E., Young, N.J., Dudhia, J., BEAMISH, I.C., & SMITH, R.K.W. (2011). Implantation of bone marrow‐derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon. <em>Equine Veterinary Journal</em>. https://doi.org/10.1111/j.2042-3306.2011.00363.x
Vancouver
Godwin E, Young NJ, Dudhia J, BEAMISH IC, SMITH RKW. Implantation of bone marrow‐derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon. Equine Veterinary Journal. 2011. doi:10.1111/j.2042-3306.2011.00363.x.
BibTeX
@unpublished{ebughe2011Implan,
title = {Implantation of bone marrow‐derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon},
author = {Ebughe Godwin and N. J. Young and Jayesh Dudhia and I. C. BEAMISH and R. K. W. SMITH},
journal = {Equine Veterinary Journal},
year = {2011},
doi = {10.1111/j.2042-3306.2011.00363.x},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2013
Open access · CC-BY
Beneficial Effects of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Naturally Occurring Tendinopathy
Epigenetics 2011
Open access · OA
Infant growth restriction is associated with distinct patterns of DNA methylation in human placentas
Stem Cell Research & Therapy 2017
Open access · CC-BY
Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue
Stem Cell Research & Therapy 2015
Open access · CC-BY
Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy
Aging 2024
Open access · CC-BY
Exploring the effects of Dasatinib, Quercetin, and Fisetin on DNA methylation clocks: a longitudinal study on senolytic interventions
Circulation Cardiovascular Genetics 2016
Open access · OA